Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Cystic Fibrosis
Trial Information
A study for patients with cystic fibrosis
A study of an investigational drug for inhalation for the treatment of cystic fibrosis. The purpose of the study is to provide the investigational drug to patients until approved for marketing by the FDA
Patient Inclusion Criteria: Patients with Cystic Fibrosis and who are six years of age or older.
Patient Exclusion Criteria: Patients must not be pregnant or currently involved in another clinical trial
Elaine Kucera, Director
St. Alexius Medical Center
810 E. Rosser Ave., Suite 202
Bismarck, ND 58501
Phone: 701-530-6950
Fax: 701-530-6970
EMail: ekucera@primecare.org
View Google Map
Research Center Information: St. Alexius Medical Center
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
